AI assistant
BioSyent Inc. — AGM Information 2020
May 6, 2020
43507_rns_2020-05-06_ff639e57-d22f-47b9-a472-cf7ce4543b6e.pdf
AGM Information
Open in viewerOpens in your device viewer
BIOSYENT INC.
NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
NOTICE is hereby given that the annual general and special meeting (the “Meeting”) of shareholders of BioSyent Inc. (the “Corporation”) will be held at registered head office of the Corporation at 2476 Argentia Road, Suite 402, Mississauga, Ontario L5N 6M1 on May 27, 2020 at 9:00 a.m. (Eastern Time) for the following purposes:
-
to receive the audited consolidated financial statements for the fiscal year ended December 31, 2019, together with the independent auditor’s report thereon;
-
to elect directors for the ensuing year;
-
to appoint auditors for the ensuing year and to authorize the directors to fix the remuneration to be paid to the auditors;
-
to consider and, if deemed appropriate, to pass, with or without variation, a resolution approving, the Corporation’s “10% rolling” stock option plan (the “ Stock Option Plan ”), as amended, in the form attached as Schedule “B” to the accompanying information circular;
-
to consider and, if deemed advisable, to pass, with or without variation, a resolution approving the restricted share unit plan of the Corporation (the “ Restricted Share Unit Plan ”), in the form attached as Schedule “C” to the accompanying information circular;
-
to consider and, if deemed advisable, to pass, with or without variation, a resolution ratifying and approving certain grants of restricted share units issued pursuant to the Restricted Share Unit Plan; and
-
to transact such other business as may properly be transacted at such meeting or at any adjournment thereof.
As a result of heightened health and safety concerns related to the COVID-19 pandemic, in person attendance at the Meeting will be limited to registered shareholders, duly appointed proxyholders, and essential personnel. The Corporation strongly encourages shareholders not to attend the Meeting in person and to consult the recommendations of the Public Health Agency of Canada, Public Health Ontario, and local public health authorities for preventing the spread of COVID-19 through the practice of physical distancing. The Corporation encourages shareholders to vote their common shares prior to the Meeting following the instructions set out in the accompanying instrument of proxy.
Shareholders not attending the Meeting in person should read the information regarding proxies contained in the accompanying information circular and the notes included with the accompanying instrument of proxy and then complete and return the proxy within the indicated time. It should be noted that the enclosed proxy is solicited by management of the Corporation, but a shareholder may amend it, if so desired, by striking out the names listed therein and inserting in the space provided the name of the person the shareholder wishes to represent them at the meeting.
DATED at Toronto, Ontario, this 13th day of April, 2020
BY ORDER OF THE BOARD
==> picture [117 x 38] intentionally omitted <==
René C. Goehrum Chairman and Chief Executive Officer